Our Diagnostic Solutions division delivers market-leading, clinically differentiated assays and instrumentation for molecular, perinatal and cytology testing.
Grounded in women’s health, Hologic is a leader in cytology in the United States and globally. ThinPrep®, the first liquid-based Pap test, was introduced more than 20 years ago, and it continues to lead the market with more than 650 million tests performed to date.1 Hologic tests are key tools used by laboratorians and providers to detect cervical disease and help improve women’s health.
Building upon our foundation in women’s health, the Diagnostic Solutions division has evolved and thrives in molecular testing. Our growing menu of Aptima® assays feature highly sensitive nucleic acid amplification tests (NAATs) for the detection of viral infections and sexually transmitted infections (STIs). Our Aptima virology portfolio includes precision testing for HIV-1, HCV and HBV. Aptima® STI assays target common STIs like gonorrhea, chlamydia and trichomoniasis. Both portfolios run on the fully automated Panther® system.
Our broad menu of molecular tests is elevated by state-of-the-art testing platforms. The Panther system is a fully automated testing platform with true sample-to-result automation, adaptable workflow options and advanced technology for maximum efficiency. The Panther Fusion® system is an evolution of the groundbreaking Panther system. The Panther Fusion respiratory assays are the premier set of assays on the Panther Fusion system.
Hologic perinatal solutions empower healthcare providers to optimize perinatal care for pregnant women and their babies. During one of the most crucial times in a family’s journey, fetal fibronectin (fFN) testing provides clinically predictive values to predict preterm labor risk. We continue to innovate in perinatal testing with an impassioned focus on improving patient outcomes and delivering peace of mind.
We are driven to help patients across the world live healthier. Our diagnostic solutions in cytology, molecular and perinatal testing continue to build upon our foundation in women’s health. As we continue on our quest to innovate, we remain focused on helping labs, clinicians and patients Be Sure when it matters most.